Navigation Links
eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety
Date:11/29/2007

Multi-stakeholder initiative will use health information technology to accelerate the timeliness and effectiveness of drug safety efforts across the U.S.

WASHINGTON, Nov. 29 /PRNewswire-USNewswire/ -- The non-profit eHealth Initiative Foundation (eHI) announced today the formation of an innovative research program designed to improve drug safety for patients. The eHI Connecting Communities for Drug Safety Collaboration is a public-private sector effort designed to test new approaches and develop replicable tools for assessing both the risks and the benefits of new drug treatments through the use of health information technology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050630/DCTH083LOGO )

Results of the collaborative effort will be placed in the public domain to accelerate the timeliness and effectiveness of drug safety efforts. Using a set of three "use cases" the project will test and evaluate the value and utility of blinded, anonymized, electronic clinical health information to detect and evaluate drug safety signals. Using clinical information -- while protecting patients' privacy -- promises to accelerate the timeliness, accuracy, and effectiveness of methods currently used to monitor drug safety and facilitate healthcare system response.

The Collaboration is coordinated and led by the eHealth Initiative, a non-profit, multi-stakeholder organization whose mission is to improve the quality, safety and efficiency of health care through information and information technology. With guidance from eHI's multi-stakeholder Leadership Council, the collaboration involves three leading healthcare companies -- Pfizer Inc., Johnson & Johnson, and Eli Lilly and Company and two community-based healthcare organizations with advanced stage clinical information systems -- Partners HealthCare System and the Regenstrief Institute.

Over a tw
'/>"/>

SOURCE eHealth Initiative
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. FRC Applauds New Ballot Initiative for Cures Without Cloning
3. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
4. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
5. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
6. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
7. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
8. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. CCPM Issues Statement on FDAs GIVE Initiative
11. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today ... 2009 will receive the dividend of shares of common ... Vivakor,s Board of Directors. HealthAmerica is a private ... the outstanding common shares on the record date. The ...
(Date:12/4/2009)... Inc. today announced that data from pre-clinical studies of its ... vitro and animal models of human chronic myeloid leukemia ... 51st Annual Meeting of the American Society of Hematology (ASH), ... The poster will be presented by Stemline,s collaborators at The ...
(Date:12/3/2009)... JourneyLite of Houston, LLC announced today ... a second surgical option, vertical sleeve gastrectomy , ... currently performs. The first sleeve gastrectomy procedure at the ... Laurent, MD on October 20, 2009. The patient ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for ... and chemotherapy. MuGard is commercially launched by Access, partner, ... Italy, Norway, Greece and Sweden. Access is conducting pre-marketing ...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4
... in CLL Patients Treated With Low Doses of ... in Combination with Established TherapeuticsPreclinical Mechanism Apoptosis in ... Other TherapeuticsSEATTLE, May 14 Trubion Pharmaceuticals, Inc. ... acceptance of three data presentations on its proprietary ...
... ANY LAB TEST NOW(R), the first retail direct-access lab ... with Atherotech, Inc., a Birmingham, Alabama-based CLIA-laboratory to provide ... affordable price. The VAP Cholesterol Test is an expanded ... at risk and is the first cholesterol test to ...
... from preclinical and Phase 1 safety studies, and plans ... prostatic hyperplasia (BPH) are to be presentedCINCINNATI, May 14 ... on medicines for an aging global population, will lead ... May 19, 2009 at 9:00 AM in Atlanta, Georgia. ...
Other Biology Technology:Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting 2Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting 3Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting 4Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting 5Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting 6VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3Ausio Pharmaceuticals to Present at Bio(R) 2009 2
(Date:12/3/2009)... the 1980s, Harald zur Hausen and his co-workers discovered ... cancer. Scientists soon found out how these pathogens cause ... main culprits are viral proteins E6 and E7. Both ... cell growth. , Professor Dr. Frank Rsl and ...
(Date:12/3/2009)... its 32nd year, the CTRC-AACR San Antonio Breast Cancer ... science and world leaders from industry and academia with ... year, more than 8,500 scientists and other professionals will ... San Antonio from Dec. 9-13, 2009. The symposium is ...
(Date:12/3/2009)... be included in the design of the upcoming forest deal ... to a scientist at the University of Leeds. , ... that at least 50% of the carbon credit payments to ... Deforestation and Degredation), should be made to forest dwellers directly, ...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 1CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 2CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 3CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 4CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 5Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 1Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 2Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 3Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 4Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 5DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 1DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 2DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 3
... Mo. According to a recent study in the ... not get enough Vitamin D. Researchers have found that ... health and increase cancer risk. Now, a University of ... deficiency is associated with inflammation, a negative response of ...
... devices bear little resemblance to the IT technologies of 20 ... even more dramatic changes to our lives. To help determine ... technology experts to join the Foresight 2030 Workshop: Harnessing the ... 2009. , The workshop the first in a ...
... -- giants of the fish world that strike terror only ... -- are imperiled by over-fishing of the species in parts ... a new study from geneticists led by Jennifer Schmidt, University ... online April 7 in the journal PLoS One . ...
Other Biology News:Vitamin D deficiency related to increased inflammation in healthy women 2COST Foresight 2030 2UIC biologists use DNA to study migration of threatened whale sharks 2
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
... kit for 10 chips provides the chips ... with the Experion automated electrophoresis system. This ... x 520 microliters Pro260 gel, 45 microliters ... kD), 400 microliters Pro260 sample buffer, and ...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... provide fast and reliable automation for ... drug development laboratories. Staccato Mini-Workstations offer ... automate basic liquid handling and material ... with either Caliper's time proven CLARA™ ...
Biology Products: